These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21658380)

  • 1. Possible involvement of β-endorphin in docosahexaenoic acid-induced antinociception.
    Nakamoto K; Nishinaka T; Ambo A; Mankura M; Kasuya F; Tokuyama S
    Eur J Pharmacol; 2011 Sep; 666(1-3):100-4. PubMed ID: 21658380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elucidation of mechanisms underlying docosahexaenoic acid-induced antinociception].
    Nishinaka T; Matsumoto K; Nakamoto K; Anbo A; Mankura M; Koyama Y; Tokuyama S
    Yakugaku Zasshi; 2013; 133(5):493-9. PubMed ID: 23649389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
    Xu JY; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 1992 Oct; 263(1):246-52. PubMed ID: 1328609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nonselective and selective opioid receptors antagonists on antinociceptive action of acetaminophen [part III].
    Bujalska M
    Pol J Pharmacol; 2004; 56(5):539-45. PubMed ID: 15591641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade.
    Hodges BL; Gagnon MJ; Gillespie TR; Breneisen JR; O'Leary DF; Hara S; Quock RM
    J Pharmacol Exp Ther; 1994 May; 269(2):596-600. PubMed ID: 8182525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of opioid receptors in the CGRP-induced antinociception in the nucleus accumbens of rats.
    Li L; Wang X; Yu LC
    Brain Res; 2010 Sep; 1353():53-9. PubMed ID: 20659434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
    Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
    Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1991 Oct; 259(1):330-6. PubMed ID: 1656027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system.
    Nakamoto K; Nishinaka T; Matsumoto K; Kasuya F; Mankura M; Koyama Y; Tokuyama S
    Brain Res; 2012 Jan; 1432():74-83. PubMed ID: 22137657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of spinal mu(1)-opioid receptors and dynorphin B to the antinociception induced by Tyr-d-Arg-Phe-Sar.
    Mizoguchi H; Ito K; Watanabe H; Watanabe C; Katsuyama S; Fujimura T; Sakurada T; Sakurada S
    Peptides; 2006 Nov; 27(11):2786-93. PubMed ID: 16919848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA.
    Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice.
    Shu H; Hayashida M; Arita H; Huang W; Zhang H; An K; Wu G; Hanaoka K
    J Pharmacol Exp Ther; 2011 Aug; 338(2):579-87. PubMed ID: 21543510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
    Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
    J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice.
    Song ZH; Takemori AE
    J Pharmacol Exp Ther; 1990 Aug; 254(2):363-8. PubMed ID: 2166788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.